Laevolac (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged, where gut bacteria break it down into short‑chain fatty acids. This process lowers the colonic pH and creates an osmotic gradient that draws water into the bowel, softening stool and stimulating peristalsis. The acidic environment also traps ammonia as ammonium, decreasing its absorption into the bloodstream.

The dose of Laevolac is individualized and determined by the prescribing healthcare professional. The prescriber will consider the patient’s condition, severity, response to therapy, and any underlying health issues before setting the appropriate dosage and titration schedule.

Safety data for lactulose in pregnancy and lactation are limited. It is generally classified as a category C medication, meaning risk cannot be ruled out. Women who are pregnant or breastfeeding should discuss potential benefits and risks with their physician before using Laevolac.

To place an order, submit an enquiry on the Laevolac product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request trade or institutional credentials. After verification, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

Laevolac (lactulose) is an osmotic laxative that works by increasing water content in the colon, whereas stimulant laxatives such as bisacodyl act by directly stimulating intestinal nerves. Polyethylene glycol (PEG) is another osmotic agent but does not produce the same acidifying effect that reduces ammonia absorption, making lactulose the preferred choice for hepatic encephalopathy.

Laevolac should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct heat, and ensure the container is tightly closed to maintain stability.

Laevolac is taken orally. The powder or liquid formulation is usually dissolved in a small amount of water or other clear fluid and consumed as directed by the prescriber. It can be taken with or without food, but consistent timing helps achieve predictable results.

The most serious risks include severe electrolyte disturbances (particularly low potassium or sodium), dehydration from excessive diarrhoea, and rare allergic reactions such as rash or swelling. Patients should seek medical attention if they experience persistent vomiting, severe abdominal pain, or signs of electrolyte imbalance.

Laevolac is contraindicated in individuals with known hypersensitivity to lactulose, intestinal obstruction, perforated bowel, or acute abdominal conditions. It should also be used with caution in patients with severe renal impairment, as they may be more susceptible to electrolyte imbalances.